{
    "clinical_study": {
        "@rank": "90688", 
        "acronym": "BiRT", 
        "arm_group": [
            {
                "arm_group_label": "Antibiotics", 
                "arm_group_type": "Experimental", 
                "description": "10 days of antibiotics, started and selected according to the antibiogram results. In case of reinfection or relapse, re-administration of antimicrobial agents will be performed according to the antibiogram results  (for a maximum of 3 cycles of ten days of antibiotics during the 12 months of the follow-up)."
            }, 
            {
                "arm_group_label": "No treatment", 
                "arm_group_type": "No Intervention", 
                "description": "no antibiotics delivered in case of asymptomatic bacteriuria, independently of the number of asymptomatic episodes."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare antibiotics versus no-treatment in kidney transplant\n      recipients with asymptomatic bacteriuria."
        }, 
        "brief_title": "The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria", 
        "condition": [
            "Asymptomatic Bacteriuria", 
            "Bacteriuria", 
            "Urinary Tract Infections", 
            "Kidney Transplantation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bacteriuria", 
                "Urinary Tract Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Kidney transplant recipient with asymptomatic bacteriuria after the first two months\n             post-transplantation\n\n        Exclusion Criteria:\n\n          -  Pregnant women or women who wish to become pregnant during the course of the study\n\n          -  Presence of indwelling urinary devices such as urethral catheter, ureteral catheter,\n             nephrostomy and/or suprapubic catheter\n\n          -  Combined transplantation (liver-kidney, lung-kidney, heart-kidney)\n\n          -  Urinary tract surgery during the last two months\n\n          -  Surgical urological procedure planned in the next 2 weeks\n\n          -  Neutropenia (\u2264 500 neutrophils/mm3)\n\n          -  Important intensification of immunosuppression (Solumedrol bolus and/or use of\n             thymoglobulin) or any other treatment of an acute graft rejection in the last two\n             months\n\n          -  Use of antibiotics at the time of the asymptomatic bacteriuria (except for prevention\n             of Pneumocystis jirovecii)\n\n          -  End-Stage Renal Disease (ESRD) requiring dialysis\n\n          -  Non-functioning native bladder (e.g. bladder dysfunction requiring intermittent\n             self-catheterization, orthotopic ileal neobladder)\n\n          -  Recurrent acute graft pyelonephritis (\u2265 2 episodes in the last year)\n\n          -  Kidney transplant recipients who could not return for regular follow-up"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "198", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01871753", 
            "org_study_id": "BiRT study", 
            "secondary_id": "2012-003857-26"
        }, 
        "intervention": {
            "arm_group_label": "Antibiotics", 
            "description": "10 days of antibiotics, started and selected according to the antibiogram results. In case of reinfection or relapse, re-administration of antimicrobial agents will be performed according to the antibiogram results  (for a maximum of 3 cycles of ten days of antibiotics during the 12 months of the follow-up)", 
            "intervention_name": "Anti-Infective Agents", 
            "intervention_type": "Other", 
            "other_name": [
                "Anti-Infective Agents: not applicable - no specific agent", 
                "The choice of antimicrobial agent is at the discretion of the physician, and is based on the antibiogram results"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Infective Agents", 
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 23, 2014", 
        "link": {
            "description": "trial website", 
            "url": "http://www.birtstudy.com"
        }, 
        "location": [
            {
                "contact": {
                    "email": "dabram@ulb.ac.be", 
                    "last_name": "Daniel Abramowicz, MD, PhD", 
                    "phone": "+32.3.821.34.35"
                }, 
                "facility": {
                    "address": {
                        "city": "Antwerpen", 
                        "country": "Belgium", 
                        "zip": "2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }, 
                "investigator": [
                    {
                        "last_name": "Daniel Abramowicz, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Jean-Louis Bosmans, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Herman Goossens, MD, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lghisdal@yahoo.com", 
                    "last_name": "Lidia Ghisdal, MD, PhD", 
                    "phone": "003265768111"
                }, 
                "facility": {
                    "address": {
                        "city": "Baudour", 
                        "country": "Belgium", 
                        "zip": "7331"
                    }, 
                    "name": "Centre Hospitalier Epicura"
                }, 
                "investigator": {
                    "last_name": "Lidia Ghisdal, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "julien.coussement@erasme.ulb.ac.be", 
                    "last_name": "Julien Coussement, MD", 
                    "phone": "+32.2.555.30.49"
                }, 
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1070"
                    }, 
                    "name": "H\u00f4pital Universitaire Erasme"
                }, 
                "investigator": [
                    {
                        "last_name": "Julien Coussement, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Fr\u00e9d\u00e9rique Jacobs, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Sandrine Roisin, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Nilufer Broeders, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mireille.kianda@erasme.ulb.ac.be", 
                    "last_name": "Mireille Kianda, MD", 
                    "phone": "+32.2.477.26.41"
                }, 
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1020"
                    }, 
                    "name": "Centre Hospitalier Universitaire Brugmann"
                }, 
                "investigator": {
                    "last_name": "Mireille Kianda, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "karlmartin.wissing@uzbrussel.be", 
                    "last_name": "Karl M Wissing, MD, PhD", 
                    "phone": "+32.2.477.60.55"
                }, 
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1090"
                    }, 
                    "name": "Universitair Ziekenhuis Brussel - Vrije Universiteit Brussel"
                }, 
                "investigator": {
                    "last_name": "Karl M Wissing, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "philippe.madhoun@chu-charleroi.be", 
                    "last_name": "Philippe Madhoun, MD", 
                    "phone": "+32.7.192.11.82"
                }, 
                "facility": {
                    "address": {
                        "city": "Charleroi", 
                        "country": "Belgium", 
                        "zip": "6110"
                    }, 
                    "name": "Centre Hospitalier Universitaire de Charleroi"
                }, 
                "investigator": {
                    "last_name": "Philippe Madhoun, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "patrick.peeters@ugent.be", 
                    "last_name": "Patrick Peeters, MD", 
                    "phone": "+32.9.332.27.42"
                }, 
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium", 
                        "zip": "9000"
                    }, 
                    "name": "Universitair Ziekenhuis Gent"
                }, 
                "investigator": [
                    {
                        "last_name": "Patrick Peeters, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Steven Van Laecke, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "l.weekers@chu.ulg.ac.be", 
                    "last_name": "Laurent Weekers, MD", 
                    "phone": "+32.4.366.74.05"
                }, 
                "facility": {
                    "address": {
                        "city": "Li\u00e8ge", 
                        "country": "Belgium", 
                        "zip": "4000"
                    }, 
                    "name": "Centre Hospitalier Universitaire de Li\u00e8ge"
                }, 
                "investigator": {
                    "last_name": "Laurent Weekers, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mhazzan@gmail.com", 
                    "last_name": "Marc Hazzan, MD, PhD", 
                    "phone": "+33.3.20.44.67.70"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Centre Hospitalier R\u00e9gional Universitaire de Lille"
                }, 
                "investigator": {
                    "last_name": "Marc Hazzan, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "anne.scemla@nck.aphp.fr", 
                    "last_name": "Anne Scemla, MD", 
                    "phone": "+33.1.44.49.54.41"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75015"
                    }, 
                    "name": "Department of Kidney Transplantation, H\u00f4pital Necker Enfants-Malades, Universit\u00e9 de Paris Descartes, APHP"
                }, 
                "investigator": {
                    "last_name": "Anne Scemla, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "France"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "The Bacteriuria in Renal Transplantation (BiRT) Study: A Prospective, Randomized, Parallel-group, Multicenter, Open-label, Superiority Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria", 
        "overall_contact": {
            "email": "julien.coussement@erasme.ulb.ac.be", 
            "last_name": "Julien Coussement, MD", 
            "phone": "003225553111"
        }, 
        "overall_official": {
            "affiliation": "H\u00f4pital Universitaire Erasme, Brussels, Belgium", 
            "last_name": "Julien Coussement, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "cumulative incidence of a first episode of symptomatic urinary tract infection", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01871753"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Erasme University Hospital", 
            "investigator_full_name": "Dr Coussement Julien", 
            "investigator_title": "Julien Coussement, MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "incidence of a first episode of pyelonephritis", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "clearance of asymptomatic bacteriuria", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "occurrence of new episodes of asymptomatic bacteriuria", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "graft function/graft survival", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "incidence of graft rejection", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "patient survival", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "utility of a control urine culture for diagnosis of asymptomatic bacteriuria in kidney transplant recipients", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "level of antimicrobial resistance in bacteria responsible for symptomatic urinary tract infections", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "total number of days of antimicrobial therapy", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "cost of antimicrobial treatment for asymptomatic bacteriuria and symptomatic urinary tract infection", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "number of hospitalizations for asymptomatic bacteriuria and symptomatic urinary tract infection treatment", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "total number of symptomatic urinary tract infections in both groups", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Erasme University Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Universitair Ziekenhuis Brussel", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "H\u00f4pital Necker Enfants-Malades, Universit\u00e9 de Paris Descartes, APHP, France", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Centre Hospitalier R\u00e9gional Universitaire de Lille, France", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Centre Hospitalier Universitaire Brugmann", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Centre Hospitalier Universitaire de Charleroi", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Universitair Ziekenhuis Gent, Belgium", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Centre Hospitalier Epicura, Belgium", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital of Liege", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Erasme University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}